Divestiture positions Argon to increase focus on the growth and expansion of its Interventional business

Plano, TX, February 6, 2017— Argon Medical Devices, Inc. (“Argon”), a leading global marketer and manufacturer of specialty medical devices used in Interventional procedures, announced today that it has completed the sale of its Critical Care business (“Critical Care”), including a manufacturing facility in Yishun, Singapore and related commercial operations in Europe and Japan, to Merit Medical Systems, Inc. (“Merit”, Nasdaq: MMSI). The sale of the Critical Care Unit allows Argon to focus solely on its Interventional business worldwide.  “The divestiture of the non-strategic, Critical Care business, is a further step toward concentrating attention of the entire business on our higher growth, Interventional portfolio.” said George Leondis, President and CEO of Argon.  The financial terms of the transaction were not disclosed.

 

About Argon Medical Devices, Inc.

Argon Medical Devices, Inc., based in Plano, TX, is a privately-held, global manufacturer and marketer of single-use specialty medical devices for Interventional procedures. Through a network of direct sales representatives and premier distributors, Argon supplies physician customers with breakthrough technologies to improve clinical efficiency and outcomes.  The Argon product portfolio is highlighted by the OptionELITE retrievable IVC Filter, Cleaner and Cleaner15 Rotational Thrombectomy Systems, BioPince Full-core Biopsy Instrument, TLAB Transjugular Liver Biopsy Instrument, Atrieve Vascular Snare, Skater Drainage Systems and T-Lok Bone Marrow Biopsy Needles.